Periodic Reporting for period 2 - MOLEC ANTI-ARRHYT (Resilience and Trigger Factors in Cardiac Arrhythmia: Risk Stratification and Drug Design)

Cardiac arrhythmias comprise a group of syndromes with various clinical outcomes, the most severe of which are life-threatening arrhythmias and sudden cardiac death. Although numerous mutations in the genes encoding for cardiac ion channels have been identified as an...